// App-Quantinova.ai

3530 : Multicenter phase I/II trial of BBI608 and pembrolizumab combination in patients with metastatic colorectal cancer (SCOOP Study): EPOC1503.

Researchers

Presenter

  • Eiji Shinozaki

Principal Investigators

  • Yasutoshi Kuboki

  • Yoshito Komatsu

  • Tomohiro Nishina

  • Hiroki Hara

  • Satoshi Yuki

  • Kohei Shitara

  • Hideaki Bando

  • Daisuke Kotani

  • Koji Takahashi

  • Yuichi Mikamoto

  • Hiromi Hasegawa

  • Nami Hirano

  • Shogo Nomura

  • Yosuke Togashi

  • Hiroyoshi Nishikawa

  • Akihiro Sato

  • Atsushi Ohtsu

  • Takayuki Yoshino

Medical Centers

  • Department of Pharmacy,The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan

  • National Cancer Center Hospital, Tokyo, Japan

  • Gastric Surgery Division, National Cancer Center Hospital East, Kashiwa, Japan

  • Cancer Center, Hokkaido University Hospital, Sapporo, Japan

  • Shikoku Cancer Center, Matsuyama, Japan

  • Department of Gastroenterology, Chiba Cancer Center, Chiba, Japan

  • Department of Gastroenterology and Hepatology, Hokkaido University Hospital, japan, Sapporo, Japan

  • National Cancer Center, EPOC, Chiba, Japan

  • Depertment of Surgical Oncology, National Cancer Center Hospital East, Chiba, Japan

  • National Cancer Center Hospital, Tokyo, Japan

  • Clinical Research Support Office, National Cancer Center Hospital East, Chiba, Japan

  • National Cancer Center Hospital, Tokyo, Japan

  • Biostatistics Division, Center for Research Administration and Support, National Cancer Center, Japan, Chiba, Japan

  • Division of Cancer Immunology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Hospital East, Kashiwa, Japan

  • Clinical Research Support Office, National Cancer Center Hospital East, Chiba, Japan

  • National Cancer Center Hospital, Tokyo, Japan

  • Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan, Kashiwa, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

  • BBI-608

Outcome

  • Unknown

Study Design

  • Multicenteric

  • Cohort

Phase

  • II

Study Id's

  • NCT02851004

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved